Compounds > tolbutamide
Page last updated: 2024-08-16

tolbutamide and glucagon-like peptide 1

tolbutamide has been researched along with glucagon-like peptide 1 in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (33.33)18.2507
2000's5 (41.67)29.6817
2010's3 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobashi, Y; Kanno, T; Nakano, K; Suga, S; Takeo, T; Wakui, M1
Nakata, M; Tanaka, H; Yada, T; Yaekura, K1
Yada, T; Yaekura, K; Yanagida, K1
Fernandez, J; Valdeolmillos, M1
Ding, WG; Kitasato, H; Matsuura, H1
Gribble, FM; Reimann, F1
Katakai, T; Mitaka, T; Miyazaki, J; Nakajima-Nagata, N; Sakurai, T; Shimizu, A; Sugai, M; Tabata, Y; Yamato, E1
de Heer, J; Holst, JJ1
Fukuda, S; Ishii, Y; Matsui, K; Matsushita, M; Miyajima, K; Nishizawa, E; Oda, T; Ohta, T; Sano, R; Sasase, T; Ueda, N; Yamamoto, H1
Cui, Z; Li, Z; Meng, F; Sun, H; Zhang, H; Zhang, J1
Guerra, ML; Hockerman, GH; Jarrard, RE; Lange, AM; Pratt, EP; Salyer, AE; Soderling, IM; Wang, Y1
Abdel-Wahab, YH; Flatt, PR; McKillop, AM; Ng, MT1

Other Studies

12 other study(ies) available for tolbutamide and glucagon-like peptide 1

ArticleYear
GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.
    Diabetes, 1997, Volume: 46, Issue:11

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Barium; Bucladesine; Calcium Channels; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP; Electric Stimulation; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Rats; Thionucleotides; Tolbutamide

1997
Cyclic AMP, a mediator of GLP-1, acts in concert with glucose and tolbutamide to increase cytosolic Ca2+ in pancreatic B-cells.
    Advances in experimental medicine and biology, 1997, Volume: 426

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Calcium; Cells, Cultured; Colforsin; Cyclic AMP; Cytosol; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Islets of Langerhans; Peptide Fragments; Potassium Chloride; Rats; Rats, Wistar; Tolbutamide

1997
PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by high K+.
    Annals of the New York Academy of Sciences, 1998, Dec-11, Volume: 865

    Topics: Animals; Arginine; Calcium; Cells, Cultured; Glucagon; Glucagon-Like Peptide 1; Glucose; Islets of Langerhans; Neuropeptides; Nifedipine; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Potassium Chloride; Protein Precursors; Rats; Rats, Wistar; Tolbutamide

1998
Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo.
    Diabetes, 1999, Volume: 48, Issue:4

    Topics: Animals; Blood Glucose; Electrophysiology; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Osmolar Concentration; Peptide Fragments; Tolbutamide

1999
Involvement of calmodulin in glucagon-like peptide 1(7-36) amide-induced inhibition of the ATP-sensitive K+ channel in mouse pancreatic beta-cells.
    Experimental physiology, 2001, Volume: 86, Issue:3

    Topics: Adenosine Triphosphate; Animals; Calcium; Calmodulin; Electrophysiology; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Hypoglycemic Agents; Imidazoles; Islets of Langerhans; Male; Membrane Potentials; Mice; Mice, Inbred ICR; Peptide Fragments; Potassium Channels; Sulfonamides; Tolbutamide

2001
Glucose-sensing in glucagon-like peptide-1-secreting cells.
    Diabetes, 2002, Volume: 51, Issue:9

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Cell Line; Cell Membrane; Diazoxide; Electric Conductivity; Glucagon; Glucagon-Like Peptide 1; Glucokinase; Glucose; Glycosyltransferases; Hypoglycemic Agents; Membrane Proteins; Peptide Fragments; Potassium Channels; Potassium Channels, Inwardly Rectifying; Protein Precursors; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae Proteins; Tolbutamide

2002
In vitro induction of adult hepatic progenitor cells into insulin-producing cells.
    Biochemical and biophysical research communications, 2004, Jun-04, Volume: 318, Issue:3

    Topics: Animals; Cell Differentiation; Gene Expression Profiling; Glucagon; Glucagon-Like Peptide 1; Glucose; Hepatocytes; Homeodomain Proteins; Insulin; Insulin Secretion; Liver; Male; Peptide Fragments; Potassium; Protein Precursors; Rats; Rats, Sprague-Dawley; Stem Cells; Time Factors; Tolbutamide; Trans-Activators; Transfection

2004
Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    Diabetes, 2007, Volume: 56, Issue:2

    Topics: Animals; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucose; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Potassium Channels; Rats; Rats, Wistar; Somatostatin; Tolbutamide

2007
Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.
    Experimental animals, 2009, Volume: 58, Issue:4

    Topics: Animals; Arginine; Benzoates; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity; Organ Culture Techniques; Pancreas; Peptide Fragments; Rats; Rats, Sprague-Dawley; Tolbutamide

2009
Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Models, Biological; Rats; Rats, Wistar; Tissue Engineering; Tissue Survival; Tolbutamide

2013
Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells.
    Molecular endocrinology (Baltimore, Md.), 2014, Volume: 28, Issue:4

    Topics: Action Potentials; Animals; Calcium; Calcium Channels, L-Type; Cell Fractionation; Centrifugation, Density Gradient; Cyclic AMP; Endocytosis; Endoplasmic Reticulum; Eukaryotic Initiation Factor-3; Glucagon-Like Peptide 1; Glucose; Immunoprecipitation; Insulin; Insulin Secretion; Insulin-Secreting Cells; Intracellular Space; Ion Channel Gating; Male; Protein Structure, Secondary; ras GTPase-Activating Proteins; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Tolbutamide; Verapamil

2014
Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
    Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:10

    Topics: Animals; C-Peptide; Cell Line; Diazoxide; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mice; Rats; Tolbutamide

2014